Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementation (Q90482568)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32194983%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

review article

1 reference

title

Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32194983%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32194983%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Magnus Ingelman-Sundberg

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32194983%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

publication date

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32194983%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32194983%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32194983%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32194983%20AND%20SRC:MED&resulttype=core&format=json

Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions

14 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

A New Panel-Based Next-Generation Sequencing Method for ADME Genes Reveals Novel Associations of Common and Rare Variants With Expression in a Human Liver Cohort

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Rare-variant association analysis: study designs and statistical tests

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

An integrated map of genetic variation from 1,092 human genomes

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

A systematic survey of loss-of-function variants in human protein-coding genes

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Genetic variation in the human cytochrome P450 supergene family

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Genetic variability and population diversity of the human SLCO (OATP) transporter family

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Analysis of population-specific pharmacogenomic variants using next-generation sequencing data.

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

The global spectrum of protein-coding pharmacogenomic diversity.

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Integrating rare genetic variants into pharmacogenetic drug response predictions.

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Pharmacogenomics of GPCR Drug Targets

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Assembly and diploid architecture of an individual human genome via single-molecule technologies

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Sequencing of human genomes with nanopore technology

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Long read nanopore sequencing for detection of HLA and CYP2D6 variants and haplotypes

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Long-Read Single Molecule Real-Time Full Gene Sequencing of Cytochrome P450-2D6.

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing.

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Single molecule real-time DNA sequencing of HLA genes at ultra-high resolution from 126 International HLA and Immunogenetics Workshop cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Predicting deleterious amino acid substitutions

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

A method and server for predicting damaging missense mutations

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Predicting the functional effect of amino acid substitutions and indels

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

MutationTaster2: mutation prediction for the deep-sequencing age.

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

FATHMM-XF: accurate prediction of pathogenic point mutations via extended features

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

A general framework for estimating the relative pathogenicity of human genetic variants

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

A spectral approach integrating functional genomic annotations for coding and noncoding variants

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

An optimized prediction framework to assess the functional impact of pharmacogenetic variants

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Deep mutational scanning: a new style of protein science

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

A rapid, efficient, and economical inverse polymerase chain reaction-based method for generating a site saturation mutant library

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Plasmid-based one-pot saturation mutagenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

The spatial architecture of protein function and adaptation

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Analyses of the effects of all ubiquitin point mutants on yeast growth rate

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

A comprehensive, high-resolution map of a gene's fitness landscape

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Combining natural sequence variation with high throughput mutational data to reveal protein interaction sites

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

High-resolution mapping of protein sequence-function relationships

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Prospective functional classification of all possible missense variants in PPARG.

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Multiplex assessment of protein variant abundance by massively parallel sequencing

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Quantitative Missense Variant Effect Prediction Using Large-Scale Mutagenesis Data.

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Predicting the clinical impact of human mutation with deep neural networks

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk.

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

DeepPVP: phenotype-based prioritization of causative variants using deep learning

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

A randomized trial of genotype-guided dosing of warfarin

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

CYP2D6 Genetic Variation and Beta-Blocker Maintenance Dose in Patients with Heart Failure

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

The effect of the CYP2D6 genotype on the maintenance dose of metoprolol in a chronic Dutch patient population

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Racial/ethnic differences in drug disposition and response: review of recently approved drugs

1 reference

https://api.crossref.org/works/10.1038%2FS41525-020-0119-2

7 January 2021

Premature termination codons in modern human genomes

1 reference

12 December 2020

Algorithm for predicting low maintenance doses of warfarin using age and polymorphisms in genes CYP2C9 and VKORC1 in Brazilian subjects

1 reference

12 December 2020

Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and detection of duplications

1 reference

12 December 2020

The genetic landscape of the human solute carrier (SLC) transporter superfamily

1 reference

12 December 2020

10.1038/S41525-020-0119-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32194983%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32194983%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

PubMed publication ID

32194983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32194983%20AND%20SRC:MED&resulttype=core&format=json